Genetic factors in pancreatitis.
The understanding of pathogenesis of acute and chronic pancreatitis has benefited from the progress made in genetic investigations. The discoveries of the gain of function mutations of cationic trypsinogen gene (PRSS1) and the loss of function mutations of pancreatic secretory trypsin inhibitor (SPINK 1) or other potential defects in genes that regulate pancreatic secretory function or modulate inflammatory response to pancreatic injury has changed our current concepts on the pathogenesis of pancreatitis. Genetic factors play an important role in the susceptibility to pancreatic injury, severity and evolution of inflammatory process, leading in some cases to chronic inflammation and/or fibrosis. Acute pancreatitis is viewed as an event and chronic pancreatitis as a process, sequentially linked, reflecting a complex interaction between genetic and environmental factors.
Grigorescu
Mircea
M
3rd Medical Clinic, University of Medicine and Pharmacy, Str. Croitorilor 19-21, 400162 Cluj-Napoca, Romania.
Grigorescu
Mircea Dan
MD
D002352:Carrier Proteins / Q000235:genetics* / Q000494:pharmacology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics* / Q000494:pharmacology; D004252:DNA Mutational Analysis; D005355:Fibrosis; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D007249:Inflammation; D010179:Pancreas / Q000502:physiology; D010195:Pancreatitis / Q000235:genetics* / Q000503:physiopathology*; D014357:Trypsin / Q000235:genetics* / Q000494:pharmacology; D014359:Trypsin Inhibitor, Kazal Pancreatic; D014362:Trypsinogen / Q000235:genetics* / Q000494:pharmacology
C505032:CFTR protein, human; D002352:Carrier Proteins; C486642:SPINK1 protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D014359:Trypsin Inhibitor, Kazal Pancreatic; D014362:Trypsinogen; C489303:PRSS1 protein, human; D014357:Trypsin